Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Deafness × Acetylcysteine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pseudomyxoma Peritonei 1 Neoplasms, Cystic, Mucinous, and Serous 1 Hearing Loss, Sensorineural 1 Hearing Loss 1 Head and Neck Neoplasms 1 Ear Diseases 1 Deafness 1 Carcinoma, Hepatocellular 1 Adenocarcinoma, Mucinous 1

Interventions

ebselen 1 Acetylcysteine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04291209 2023-09-06

Intratympanic N-Acetylcysteine for Prevention of Cisplatin-induced Ototoxicity.

Sunnybrook Health Sciences Centre

Phase 1/2 Unknown

Deafness, Ear Diseases, Hearing Loss, Sensorineural, Hearing Loss

Data powered by HemOnc (CC BY 4.0) Colophon ⚡